Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Khamis Tomusange

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|April 5, 2017
Human Rhinovirus-A1 as an Expression VectorKhamis Tomusange, Danushka Wijesundara, Eric James Gowans, et al.
Virus Research|April 15, 2015
Engineering human rhinovirus serotype-A1 as a vaccine vectorKhamis Tomusange, Wenbo Yu, Andreas Suhrbier, et al.
Scientific Reports|November 18, 2016
Mucosal vaccination with a live recombinant rhinovirus followed by intradermal DNA administration elicits potent and protective HIV-specific immune responsesKhamis Tomusange, Danushka Wijesundara, Jason Gummow, et al.
Mabs|May 21, 2025
Development and characterization of AD-214, an anti-CXCR4 i-body-Fc fusion for the treatment of idiopathic pulmonary fibrosisJason P Lynch, Louise Organ, Khamis Tomusange, et al.
Scientific Reports|July 1, 2016
A HIV-Tat/C4-binding protein chimera encoded by a DNA vaccine is highly immunogenic and contains acute EcoHIV infection in miceKhamis Tomusange, Danushka Wijesundara, Jason Gummow, et al.
British Journal of Pharmacology|August 12, 2017
Discovery and pharmacological characterization of a novel series of highly selective inhibitors of cyclin-dependent kinases 4 and 6 as anticancer agentsSolomon Tadesse, Laychiluh Bantie, Khamis Tomusange, et al.
Journal of Medicinal Chemistry|February 4, 2017
Highly Potent, Selective, and Orally Bioavailable 4-Thiazol-N-(pyridin-2-yl)pyrimidin-2-amine Cyclin-Dependent Kinases 4 and 6 Inhibitors as Anticancer Drug Candidates: Design, Synthesis, and EvaluationSolomon Tadesse, Mingfeng Yu, Laychiluh B Mekonnen, et al.
AIDS (London, England)|May 16, 2018
Anti-HIV IgM protects against mucosal SHIV transmissionSiqi Gong, Khamis Tomusange, Viraj Kulkarni, et al.
Journal of Virology|March 23, 2018
Central Nervous System Inflammation and Infection during Early, Nonaccelerated Simian-Human Immunodeficiency Virus Infection in Rhesus MacaquesDenise C Hsu, Piyanate Sunyakumthorn, Matthew Wegner, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|April 5, 2017
Human Rhinovirus-A1 as an Expression VectorKhamis Tomusange, Danushka Wijesundara, Eric James Gowans, et al.
Virus Research|April 15, 2015
Engineering human rhinovirus serotype-A1 as a vaccine vectorKhamis Tomusange, Wenbo Yu, Andreas Suhrbier, et al.
Scientific Reports|November 18, 2016
Mucosal vaccination with a live recombinant rhinovirus followed by intradermal DNA administration elicits potent and protective HIV-specific immune responsesKhamis Tomusange, Danushka Wijesundara, Jason Gummow, et al.
Mabs|May 21, 2025
Development and characterization of AD-214, an anti-CXCR4 i-body-Fc fusion for the treatment of idiopathic pulmonary fibrosisJason P Lynch, Louise Organ, Khamis Tomusange, et al.
Scientific Reports|July 1, 2016
A HIV-Tat/C4-binding protein chimera encoded by a DNA vaccine is highly immunogenic and contains acute EcoHIV infection in miceKhamis Tomusange, Danushka Wijesundara, Jason Gummow, et al.
British Journal of Pharmacology|August 12, 2017
Discovery and pharmacological characterization of a novel series of highly selective inhibitors of cyclin-dependent kinases 4 and 6 as anticancer agentsSolomon Tadesse, Laychiluh Bantie, Khamis Tomusange, et al.
Journal of Medicinal Chemistry|February 4, 2017
Highly Potent, Selective, and Orally Bioavailable 4-Thiazol-N-(pyridin-2-yl)pyrimidin-2-amine Cyclin-Dependent Kinases 4 and 6 Inhibitors as Anticancer Drug Candidates: Design, Synthesis, and EvaluationSolomon Tadesse, Mingfeng Yu, Laychiluh B Mekonnen, et al.
AIDS (London, England)|May 16, 2018
Anti-HIV IgM protects against mucosal SHIV transmissionSiqi Gong, Khamis Tomusange, Viraj Kulkarni, et al.
Journal of Virology|March 23, 2018
Central Nervous System Inflammation and Infection during Early, Nonaccelerated Simian-Human Immunodeficiency Virus Infection in Rhesus MacaquesDenise C Hsu, Piyanate Sunyakumthorn, Matthew Wegner, et al.
Pageof 1